當前位置:首頁>學者列表>中醫藥學院(FC) >吳其標>發佈文章列表[所有]
排序方式:
    總頁 10 
      Go

    1.Targeting regulated cell death (RCD) with naturally derived sesquiterpene lactones in cancer therapy

    Xu, C, Wen, SD, Du,     More...

    Pharmacological Research[1043-6618], Published 2025, Volume 211,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  9.1 

    2.Elucidating the Role of Estrogen Effects in Leukemia: Insights from Single-Cell RNA Sequencing and Mendelian Randomization

    Zhao, JH, Yu, Y, Liu     More...

    Journal of Cancer[1837-9664], Published 2025, Volume 16, Issue 3, Pages 888-897

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  3.3 

    3.Lingguizhugan Decoction in the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

    Lu, Yifan, Nie, Liju     More...

    Endocrine, Metabolic & Immune Disorders - Drug Targets[1871-5303], Published 2025,

    收錄情况: SCOPUS

    2023影響因子:  2.0 

    4.Benchmark of Data Integration in Single-Cell Proteomics

    Gong, YG, Dai, YB, W     More...

    ANALYTICAL CHEMISTRY[0003-2700], Published 2025,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  6.8 

    5.Efficacy of Auricular Therapy for Motor Impairment After Stroke: A Systematic Review and Meta-Analysis

    Mao, YQ, Xu, DH, Yan     More...

    INTERNATIONAL JOURNAL OF OLDER PEOPLE NURSING[1748-3735], Published 2025, Volume 20, Issue 1,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  1.6 

    6.Multimodal omics analysis of the EGFR signaling pathway in non-small cell lung cancer and emerging therapeutic strategies

    Yuzheng Li, Lili Yu,     More...

    ONCOLOGY RESEARCH[0965-0407], Published 2025,

    2023影響因子:  2.0 

    7.Comparison of TPF and PF induction chemotherapy combined with cisplatin concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: A systematic review and meta-analysis

    Li, HW, Wu, QB, Luo,     More...

    MEDICINE[0025-7974], Published 2025, Volume 104, Issue 3, Pages e41278

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  1.4 

    8.B-cell signatures characterize the immune landscape and predict LUAD prognosis via the integration of scRNA-seq and bulk RNA-seq

    Xu, KX, Han, D, Fan,     More...

    Scientific Reports[2045-2322], Published 2025, Volume 15, Issue 1,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  3.8 

    9.Rutecarpine Suppresses Non-Small Cell Lung Cancer Progression Through Activating the STING Pathway and Elevating CD8+ T Cells

    Jiang, ZB, He, QH, K     More...

    Chemical Biology & Drug Design[1747-0277], Published 2025, Volume 105, Issue 2,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  3.2 

    10.Synergistic Strategies for Lung Cancer Immunotherapy: Combining Phytochemicals and Immune-Checkpoint Inhibitors

    Gao, Q, Wu, H, Li, Z     More...

    PHYTOTHERAPY RESEARCH[0951-418X], Published 2025,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  6.1 

    11.Multi-approach analysis reveals the mechanism by which Shugan Xiaozhi decoction protects against metabolic dysfunction-associated steatohepatitis

    Wang, Shuai, Du, Rui     More...

    Phytomedicine[0944-7113], Published 2025, Volume 141,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  6.7 

    12.Systemic inflammatory biomarkers as mediators of the association between dietary flavonoids and sleep disorders in patients with hypertension: A population-based study

    Wang, Xiao Jie, Hu,     More...

    Journal of Functional Foods[1756-4646], Published 2025, Volume 128,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  3.8 

    13.Tubeimoside I inhibits the growth of triple-negative breast cancer via the NR3 C2/PI3 K/AKT signaling pathway.

    Zhang, QX, Cheng, WJ     More...

    Naunyn-Schmiedeberg's Archives of Pharmacology[0028-1298], Published 2025,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  3.1 

    14.Linking Hyperuricemia to Cancer: Emerging Evidence on Risk and Progression

    Zhao, LY, Guo, RH, Z     More...

    CURRENT ONCOLOGY REPORTS[1523-3790], Published 2025,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  4.7 

    15.基于“正虚伏毒”理论探讨乳腺癌的病机与治疗

    赖胜蓝,钱军,李可帅,周华,吴其标

    辽宁中医药大学学报[1673-842X], Published 2025,

    收錄情况: CNKI

    16.Extracellular vesicles as a promising platform of precision medicine in liver cancer.

    Keyang Xu, Qibiao Wu     More...

    Pharmacol Research[1043-6618], Published 2025,

    2023影響因子:  9.1 

    17.Identification of Quercetin as a Natural MMP1 Inhibitor for Overcoming Cisplatin Resistance in Epithelial Ovarian Cancer

    Shubo Wang, Ziming Z     More...

    Journal of Cancer[1837-9664], Published 2025, Volume 16, Issue 8, Pages 2578-2594

    2023影響因子:  3.3 

    18.Hirudin inhibit the formation of NLRP3 inflammasome in cardiomyocytes via suppressing oxidative stress and activating mitophagy

    Luo, Gang, Chen, Li,     More...

    Heliyon[2405-8440], Published 2024, Volume 10, Issue 1,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  3.4 

    19.Immunoregulatory functions and therapeutic potential of natural killer cell-derived extracellular vesicles in chronic diseases

    He, S, Su, LQ, Hu, H     More...

    Frontiers in Immunology[1664-3224], Published 2024, Volume 14,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 12  2023影響因子:  5.7 

    20.Tanshinone IIA induces ER stress and JNK activation to inhibit tumor growth and enhance anti-PD-1 immunotherapy in non-small cell lung cancer

    Zhang, YZ, Lai, HL,     More...

    Phytomedicine[0944-7113], Published 2024, Volume 128,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  6.7 

    顯示      條  合計  195  條
      總頁 10 
        Go

      本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器

      Copyright © 2018 澳門科技大學學者庫